Diabetes Drug Market Projected to Acquire USD 103.52 Billion by 2032, Growing Almost 5.90% CAGR

According to the research report, the global diabetes drug market was valued at USD 61.75 billion in 2023 and is expected to reach USD 103.52 billion by 2032, to grow at a CAGR of 5.90% during the forecast period.

People of all ages are susceptible to the prevalent illness known as diabetes. Diabetes can take different forms. The most typical type is type 2. Diabetes medications are prescribed to treat both type 1 and type 2 diabetes mellitus while preserving the body's normal blood glucose levels.

There are numerous pharmacological classes available to treat diabetes, and these medications can be injected intravenously or subcutaneously for the treatment of gestational diabetes, impaired glucose tolerance, impaired fasting glucose, and impaired glucose tolerance.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐆𝐞𝐭 𝐀 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-diabetes-drug-market/request-for-sample

𝐇𝐞𝐫𝐞 𝐀𝐫𝐞 𝐒𝐨𝐦𝐞 𝐎𝐟 𝐓𝐡𝐞 𝐌𝐚𝐣𝐨𝐫 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

• Novo Nordisk A/S
• Merck &Co.
• Novartis AG.
• Eli Lily and Company
• Johnson & Johnson
• Boehringer Ingelheim GmbH
• Sanofi
• AstraZeneca
• Pfizer
• Roche Holding AG

An individual is more likely to be overweight or obese due to their bad eating habits and more sedentary lifestyle in cities. Being overweight or obese basically raises the risk of developing type 2 diabetes because fat cells in the body are less receptive to the insulin that the pancreas secretes. Additionally, the market now has more effective and reasonably priced medications, including insulin, due to rising drug approvals and fierce rivalry among pharmaceutical companies. This improves the market's growth prospects going forward.

𝐌𝐚𝐫𝐤𝐞𝐭'𝐬 𝐌𝐚𝐣𝐨𝐫 𝐅𝐚𝐜𝐭𝐬

1. The global diabetes drug market was valued at USD 61.75 billion in 2023 and is expected to grow to USD 103.52 billion.

2. The market is anticipated to expand at a CAGR of 5.9% during the forecast period.

3. In 2022, North America is anticipated to dominate the market.

4. Asia Pacific witnesses the highest growth rate in the market.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐖𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬: https://www.polarismarketresearch.com/buy/2009/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

• 𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞: The primary driver of the diabetes drug market is the increasing prevalence of diabetes globally. Factors such as sedentary lifestyles, unhealthy diets, and aging populations contribute to the growing number of people diagnosed with diabetes.

• 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭: Continuous research and development efforts have led to the introduction of innovative drugs with improved efficacy and fewer side effects. This drives market growth as healthcare providers seek better treatment options for their patients.

• 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬: Technological advancements in drug delivery systems, such as insulin pumps and continuous glucose monitoring devices, enhance the management of diabetes and drive demand for associated medications.

• 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐩𝐞𝐧𝐝𝐢𝐧𝐠: Growing awareness about diabetes management and increasing healthcare expenditure, particularly in emerging economies, contribute to market expansion.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬: https://www.polarismarketresearch.com/industry-analysis/global-diabetes-drug-market

𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐃𝐫𝐮𝐠 𝐜𝐥𝐚𝐬𝐬 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

• Glycogen-like peptide-1 (GLP-1)
• Dipeptidyl-peptidase-4 (DPP-4)
• Sodium glucose co-transporter 2 inhibitor (SGCL2)
• Insulin
• Sulfonylureas
• Glitazones
• Others

𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

• Oral
• Intravenous
• Subcutaneous

𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗- 𝟐𝟎𝟑𝟐)

• Type 1
• Type 2

𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗- 𝟐𝟎𝟑𝟐)

• Retail Pharmacies
• Online Pharmacies
• Hospital Pharmacies

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐖𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐁𝐫𝐞𝐚𝐬𝐭 𝐏𝐮𝐦𝐩𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/wearable-breast-pumps-market

𝐀𝐜𝐭𝐢𝐧𝐢𝐜 𝐊𝐞𝐫𝐚𝐭𝐨𝐬𝐢𝐬 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/actinic-keratosis-treatment-market

𝐈𝐦𝐦𝐮𝐧𝐞 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/immune-health-supplements-market

𝐄𝐮𝐫𝐨𝐩𝐞 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐞𝐝 𝐓𝐞𝐬𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/europe-laboratory-developed-tests-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.